pleas
cite
articl
fischer
n
schultz
kluge
mayerrung
u
aepfelbach
pfefferl
clinic
evalu
rtpcr
assay
fulli
autom
system
rapid
ondemand
test
hospit
set
journal
clinic
virolog
doi
http
doi
publicli
avail
rtpcr
assay
adapt
evalu
open
mode
neumodx
system
assay
show
compar
analyt
clinic
perform
refer
assay
fast
turnaround
time
minut
randomaccess
workflow
system
make
assay
well
suit
urgent
clinic
sampl
j
u
r
n
l
p
r
e
p
r
f
background
ongo
pandem
present
uniqu
challeng
diagnost
laboratori
around
world
autom
workflow
molecular
diagnost
instrument
cope
larg
number
test
order
clinician
well
provid
fasttrack
rapid
test
highli
urgent
case
studi
evalu
ldt
neumodx
system
fulli
autom
devic
perform
extract
realtim
pcr
method
publicli
avail
rtpcr
assay
adapt
autom
system
analyt
perform
evalu
use
invitro
transcrib
rna
clinic
perform
compar
coba
refer
assay
within
lab
result
envelop
e
geneldt
display
good
analyt
perform
lod
cpml
fals
posit
evalu
crossreact
total
patient
sampl
test
egeneldt
refer
assay
posit
neg
agreement
respect
invalidr
egeneldt
show
analyt
clinic
perform
compar
refer
assay
due
randomaccess
workflow
concept
rapid
timetoresult
minut
system
well
suit
provid
fasttrack
diagnost
urgent
clinic
sampl
hospit
set
keyword
neumodx
pcr
rapid
test
introduct
earli
januari
first
identifi
like
caus
agent
cluster
case
viral
pneumonia
citi
wuhan
china
novel
viru
situat
sarbecoviru
subgenu
along
genet
distinct
rel
origin
sarscoronaviru
saw
j
u
r
n
l
p
r
e
p
r
f
rapid
spread
worldwid
eventu
prompt
declar
global
health
emerg
end
januari
outbreak
scenario
present
uniqu
challeng
diagnost
laboratori
particularli
case
respiratori
virus
clinic
symptom
larg
indistinguish
common
respiratori
pathogen
eg
influenza
polymeras
chain
reaction
pcr
assay
necessari
confirm
rule
novel
viru
varieti
suitabl
assay
made
avail
earli
outbreak
notabl
corman
et
al
cdc
swiftli
adopt
mani
lab
europ
around
world
howev
overal
test
capac
remain
limit
other
previous
demonstr
autom
molecular
diagnost
enabl
easi
scale
test
capac
substanti
cut
back
handson
time
pcrassay
assay
present
studi
use
fulli
autom
randomaccess
platform
molecular
diagnost
handl
everyth
extract
amplif
signal
detect
report
result
rna
target
timetoresult
approxim
minut
given
optim
condit
avail
open
mode
allow
rapid
implement
lab
develop
test
ldt
aim
studi
adapt
evalu
previous
publish
pcr
assay
corman
et
al
neumodx
system
accord
instruct
issu
manufactur
primerprob
mix
prepar
mix
load
ldtstrip
well
well
reaction
eg
primer
nm
probe
per
reaction
complet
run
protocol
see
testsummari
display
tabl
reagent
materi
extract
pcr
neumodx
inc
ann
arbor
usa
distribut
qiagen
use
accord
instruct
manufactur
analyt
evalu
invitro
transcrib
rna
ivtrna
viral
egen
gener
j
u
r
n
l
p
r
e
p
r
f
order
rule
potenti
crossreact
organ
present
respiratori
swab
set
predetermin
clinic
sampl
contain
varieti
respiratori
pathogen
extern
qualiti
assess
panel
sampl
instand
ev
germani
select
subject
egeneldt
clinic
specimen
use
studi
oropharyng
nasopharyng
swab
eswab
collect
kit
copan
itali
prior
analysi
roch
coba
pcr
medium
guanidin
hydrochlorid
trishcl
buffer
ad
sampl
prelysi
inactiv
sampl
briefli
vortex
load
instrument
total
clinic
prepar
split
aliquot
test
parallel
system
sampl
yield
valid
result
neumodx
system
report
invalid
j
u
r
n
l
p
r
e
p
r
f
clinic
perform
assay
analyz
compar
egeneldt
refer
method
within
lab
uct
assay
inhibit
rate
sampl
test
neg
refer
assay
relianc
manual
pcr
setup
one
fundament
limit
molecular
diagnost
come
scalabl
speed
outbreak
scenario
current
situat
studi
reusken
et
al
report
readi
test
novel
coronaviru
end
januari
almost
countri
european
union
capac
test
per
week
less
vast
major
similar
issu
report
earli
china
test
could
perform
suspect
case
due
limit
capac
recent
studi
demonstr
previous
publish
taqman
base
rtpcr
assay
endors
ecdc
adapt
run
autom
batchbas
highthroughput
system
incident
roch
recent
releas
assay
system
emerg
use
author
fda
howev
take
consider
sampl
registr
pretreat
prepar
batch
gener
report
usual
take
hour
result
made
avail
clinician
consequ
altern
workflow
requir
enabl
fasttrack
highprior
sampl
neumodx
system
fulli
autom
rtpcr
platform
perform
extract
amplif
signal
detect
without
requir
human
interact
provid
randomaccess
capabl
turnaround
time
minut
rna
target
throughput
hour
studi
adapt
rtpcr
assay
corman
et
al
use
neumodx
autom
system
analyt
clinic
perform
compar
refer
assay
show
lod
approxim
copiesml
posit
neg
agreement
respect
rel
high
inhibit
rate
suggest
sampl
prepar
procedur
optim
prepar
manuscript
sever
commerci
assay
releas
offer
rapid
randomaccess
test
minut
includ
xpert
xpress
cepheid
qiastatdx
qiagen
id
abbott
howev
clinic
evalu
assay
yet
avail
peerreview
literatur
studi
adapt
publicli
avail
screen
assay
use
open
mode
neumodx
system
assay
demonstr
compar
analyt
clinic
perform
establish
ldt
current
use
diagnost
due
randomaccess
capabl
short
turnaround
time
minut
system
well
suit
autom
mediumthroughput
routin
test
addit
highthroughput
system
allow
fasttrack
highli
urgent
clinic
sampl
j
u
r
n
l
p
r
e
p
r
f
step
denatur
sec
detect
step
anneal
sec
detect
germani
test
potenti
crossreact
egeneldt
j
u
r
n
l
p
r
e
p
r
f
posit
neg
posit
neg
invalid
total
number
tabl
result
clinic
sampl
compar
novel
egeneldt
routin
assay
sarscov
uct
system
j
u
r
n
l
p
r
e
p
r
f
